---
title: "Summit Therapeutics launches at-the-market equity program for up to $380 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293667023.md"
description: "Summit Therapeutics has launched an at-the-market equity distribution program with J.P. Morgan Securities, allowing the sale of up to $380 million in common stock. Sales will occur from time to time at prevailing or negotiated market prices, with the company retaining discretion over timing and size. J.P. Morgan will receive a commission of up to 3% of gross sales. The program utilizes the company's effective Form S-3 registration statement filed on June 9, 2026."
datetime: "2026-07-23T20:57:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293667023.md)
  - [en](https://longbridge.com/en/news/293667023.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293667023.md)
generator: "portal-rs"
---

# Summit Therapeutics launches at-the-market equity program for up to $380 million

-   Summit Therapeutics entered an at-the-market equity distribution agreement with J.P. Morgan Securities to sell up to $380 million of common stock. \* Sales can be made from time to time at prevailing market prices or negotiated prices, with the company retaining discretion over timing and size. \* J.P. Morgan will receive a commission of up to 3% of gross sales. \* The program uses the company’s effective Form S-3 registration statement filed June 9, 2026, with a prospectus supplement dated July 23, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Summit Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-314214), on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SMMT.US](https://longbridge.com/en/quote/SMMT.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [JPMO.US](https://longbridge.com/en/quote/JPMO.US.md)
- [JPX.US](https://longbridge.com/en/quote/JPX.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)

## Related News & Research

- [JP Morgan raises Fleury stake to 5.01% in shareholding disclosure](https://longbridge.com/en/news/296830195.md)
- [JPMorgan drops below 5% voting rights stake in Exail Technologies](https://longbridge.com/en/news/296903675.md)
- [REG - Pinewood Tech Gp PLC JPMorgan Chase & Co - Standard form for notification of major holdings](https://longbridge.com/en/news/297051760.md)
- [REG - JPMorgan Asset Mngt MITIE Group PLC - Form 8.3-Mitie Group plc](https://longbridge.com/en/news/296790789.md)
- [JPMorgan cuts Soitec stake to 4.57% of capital, 3.65% voting rights](https://longbridge.com/en/news/296805161.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**